Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Mesa Health was a digital health company focused on chronic disease prevention and management through software-enabled behavioral interventions. Its flagship product, Transform, was a CDC-recognized digital diabetes prevention program that combined mobile software, remote monitoring devices, and individualized and group health coaching over a 12-month program. The company emphasized culturally adapted, multilingual delivery and expanded into markets including the United States, Latin America, and the Middle East. In January 2020, Blue Mesa Health was acquired by Virgin Pulse, and its technology and curriculum were integrated into Virgin Pulse Transform. The business appears to have continued as part of the acquirer rather than as an independent operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Mesa.